Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THE BALANCE Study (lixivaptan for hyponatremia in NYHA III/IV heart failure)
2006-002567-62Phase 3Completed
- Sponsor
- CardioKine
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hyponatraemia and heart failure (HF) comparing Lixivaptan with Placebo (2 arms). Primary endpoint: Change in serum sodium at day 7. Started Dec 2007; status: completed.
02
Drugs
lixivaptan
03
Conditions
hyponatraemiaheart failure (HF)
Beyond the preview
Go deeper on 2006-002567-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002567-62.